

19 Aug 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/08/19/2283855/24675/en/Fate-Therapeutics-Announces-Positive-Interim-Clinical-Data-from-its-FT596-and-FT516-Off-the-shelf-iPSC-derived-NK-Cell-Programs-for-B-cell-Lymphoma.html